CTXR - Citius Pharmaceuticals receives FDA acceptance of resubmission for its relapsed lymphoma treatment March, 18 2024 09:26 AM Citius Pharmaceuticals Inc. 2024-03-18 09:26:42 ET More on Citius Pharmaceuticals Citius resubmits marketing application for lymphoma therapy Seeking Alpha’s Quant Rating on Citius Pharmaceuticals Historical earnings data for Citius Pharmaceuticals Financial information for Citius Pharmaceuticals For further details see: Citius Pharmaceuticals receives FDA acceptance of resubmission for its relapsed lymphoma treatment